Objectives
We aimed to investigate whether uncomplicated type A intramural hematoma
(IMHA) patients with type 2 diabetes mellitus (DM) who underwent a
“wait-and-watch strategy” and tight glycemic control had similar
clinical outcomes as patients without DM who received the same treatment
strategy.